日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Exploring survival-associated transcriptomic subtypes in ovarian cancer using RNAseq from FFPE tissues in a clinical trial cohort

利用临床试验队列中FFPE组织的RNA测序技术探索卵巢癌中与生存相关的转录组亚型

Kjeldsen, Maj K; Bagger, Frederik Otzen; Roed, Henrik; Nyvang, Gitte-Bettina; Haslund, Charlotte Aaquist; Knudsen, Anja Oer; Motavaf, Anne Krejbjerg; Malander, Susanne; Anttila, Maarit; Lindahl, Gabriel; Mäenpää, Johanna; Dimoula, Maria; Werner, Theresa; Iversen, Trine Zeeberg; Hietanen, Sakari; Fokdal, Lars; Dahlstrand, Hanna; Bjørge, Line; Birrer, Michael; Mirza, Mansoor Raza; Rossing, Maria

Beyond HRD Status: Unraveling Genetic Variants Impacting PARP Inhibitor Sensitivity in Advanced Ovarian Cancer

超越HRD状态:揭示影响晚期卵巢癌PARP抑制剂敏感性的遗传变异

Kjeldsen, Maj K; Jørgensen, Morten; Grønseth, Dina Sofie B; Schønemann-Lund, Martin; Nyvang, Gitte-Bettina; Haslund, Charlotte Aaquist; Knudsen, Anja Oer; Motavaf, Anne Krejbjerg; Malander, Susanne; Anttila, Maarit; Lindahl, Gabriel; Mäenpää, Johanna; Dimoula, Maria; Werner, Theresa L; Iversen, Trine Zeeberg; Hietanen, Sakari; Fokdal, Lars; Dahlstrand, Hanna; Bjørge, Line; Birrer, Michael J; Mirza, Mansoor R; Rossing, Maria

Safe to save blood in ovarian cancer surgery - time to change transfusion habits

卵巢癌手术中保留血液是安全的——是时候改变输血习惯了

Norbeck, Anna; Bengtsson, Jesper; Malander, Susanne; Asp, Mihaela; Kannisto, Päivi

Tru-Cut Biopsy in Gynecological Cancer: Adequacy, Accuracy, Safety and Clinical Applicability

妇科肿瘤的Tru-Cut活检:充分性、准确性、安全性和临床适用性

Asp, Mihaela; Mockute, Ingrida; Måsbäck, Anna; Liuba, Karina; Kannisto, Päivi; Malander, Susanne

Age and Referral Route Impact the Access to Diagnosis for Women with Advanced Ovarian Cancer

年龄和转诊途径会影响晚期卵巢癌女性获得诊断的机会

Norbeck, Anna; Asp, Mihaela; Carlsson, Tobias; Kannisto, Päivi; Malander, Susanne

The role of computed tomography in the assessment of tumour extent and the risk of residual disease after upfront surgery in advanced ovarian cancer (AOC)

计算机断层扫描在评估晚期卵巢癌(AOC)一线手术后肿瘤范围和残留病灶风险中的作用

Asp, Mihaela; Malander, Susanne; Wallengren, Nils-Olof; Pudaric, Sonja; Bengtsson, Johan; Sartor, Hanna; Kannisto, Päivi

Incidence and survival of epithelial ovarian, fallopian tube, peritoneal, and undesignated abdominal/pelvic cancers in Sweden 1960-2014: A population-based cohort study

1960-2014年瑞典上皮性卵巢癌、输卵管癌、腹膜癌和未明确分类的腹部/盆腔癌的发病率和生存率:一项基于人群的队列研究

Leandersson, Pia; Hogberg, Thomas; Dickman, Paul W; Malander, Susanne; Borgfeldt, Christer

A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients

多重生物标志物检测可提高HE4和CA125在卵巢肿瘤患者中的诊断性能

Leandersson, Pia; Åkesson, Anna; Hedenfalk, Ingrid; Malander, Susanne; Borgfeldt, Christer

Niraparib Maintenance Therapy in Patients With Recurrent Ovarian Cancer After a Partial Response to the Last Platinum-Based Chemotherapy in the ENGOT-OV16/NOVA Trial

在ENGOT-OV16/NOVA试验中,对接受最后一次铂类化疗后部分缓解的复发性卵巢癌患者进行尼拉帕尼维持治疗

Del Campo, Josep M; Matulonis, Ursula A; Malander, Susanne; Provencher, Diane; Mahner, Sven; Follana, Philippe; Waters, Justin; Berek, Jonathan S; Woie, Kathrine; Oza, Amit M; Canzler, Ulrich; Gil-Martin, Marta; Lesoin, Anne; Monk, Bradley J; Lund, Bente; Gilbert, Lucy; Wenham, Robert M; Benigno, Benedict; Arora, Sujata; Hazard, Sebastien J; Mirza, Mansoor R

Detecting TP53 mutations in diagnostic and archival liquid-based Pap samples from ovarian cancer patients using an ultra-sensitive ddPCR method.

利用超灵敏的 ddPCR 方法检测卵巢癌患者诊断和存档的液基巴氏涂片样本中的 TP53 突变

Arildsen Nicolai Skovbjerg, Martin de la Fuente Laura, Måsbäck Anna, Malander Susanne, Forslund Ola, Kannisto Päivi, Hedenfalk Ingrid